Wang, S., Nijland, M., Strobbe, L., Oosterveld, M., Boersma, R., Koene, H., Klerk, C., Jongh, E. D., Koster, A., Pruijt, H., Poel, M. V. D., Werkhoven, E. V., Zanders, H., Dinmohamed, A., Pegtel, M., Meek, S., Stowell, S. L., Warinske, H., Alizadeh, A. A., Kurtz, D. M., Chamuleau, M. E. (2026). Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01712